Skip to content
  • Members
  • Become a Member
Linkedin
  • About
    • What We Do
    • Member Directory
    • Board Members
  • Focus Areas
    • Access & Appropriate Use
    • Manufacturing
    • Research & Science
  • Resources
  • News
  • About
    • What We Do
    • Member Directory
    • Board Members
  • Focus Areas
    • Access & Appropriate Use
    • Manufacturing
    • Research & Science
  • Resources
  • News
Contact

Geographic scope: Global

Qiagen – Detection and Surveillance of Antibiotic Resistance Genes From Food and Fertilizer Sources Using qPCR Technology

Pfizer – Antimicrobial Testing Leadership and Surveillance (ATLAS)

Peptilogics – Innovative Peptide-Based Platform to Develop a New Class of Potent Antibiotics

iNtRON- N-Rephasin® SAL200 (Tonabacase)

GSK – Sales Incentives Programme and Healthcare Provider Engagement Model

GSK – Public-Private Partnerships to Share Knowledge and Expertise in R&D

Cepheid – Global Laboratory Initiative

Aequor – ABD (Aequor Biofilm Dispersant) Effectively Combats AMR without Toxicity or Triggering Resistance

Merck & Co., Inc. – Study for Monitoring Antimicrobial Resistance Trends (SMART)

GSK – Appropriate Use Initiatives

← Previous
Next →

The AMR Industry Alliance brings together biotech, diagnostics, generics and research-based pharmaceutical companies, to drive and measure industry progress to curb antimicrobial resistance.

  • Follow on LinkedIn

Featured

  • 2024 Year in Review
  • Manufacturing Standard
  • Access principles
  • Member companies

Explore

  • About
  • Focus Areas
  • Resources
  • News

Get involved

  • Become a Member
  • Contact
  • Media enquiries

© 2026 AMR Industry Alliance. All rights reserved.

  • Privacy Policy
  • Terms of Use
  • Privacy Centre
  • Cookie Settings